Author

J. C. Cardenas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Lovy· 1 shared A. Puebla-Huerta· 1 shared A. Zakarian· 1 shared B. O'Brien· 1 shared C. Casanova-Canelo· 1 shared C. Gonzalez-Billault· 1 shared C. Gonzalez-Seguel· 1 shared C. J. Wray· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Lovy

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Calcium (Ca2+) fluxes at Mitochondria-ER Contact Sites (MERCS) are a new target of senolysis in Therapy-Induced Senescence (TIS).

A. Puebla-Huerta, H. Huerta, C. Quezada-Gutierrez, P. Morgado-Caceres, C. Casanova-Canelo, S. Linsambarth, O. Diaz-Rivera, J. A. Lopez-Dominguez, S. Rodriguez-Lopez, G. Bustos, E. Silva-Pavez, A. Lovy, G. Quiroz, C. Gonzalez-Seguel, E. Salas-Huenuleo, , J. C. Cardenas

This study shows that inhibiting ER-mitochondria Ca2+ flux is a new target for senolysis in therapy-induced senescence.

bioRxiv · Mar 31, 2024Cell Biology

Radiofrequency ablation remodels the tumor microenvironment and promotes systemic immunomodulation in pancreatic cancer

E. Y. Faraoni, N. C. Thosani, B. O'Brien, L. N. Strickland, V. Y. Mota, J. K. Chaney, P. Cen, J. Rowe, J. C. Cardenas, K. L. Poulsen, C. J. Wray, J. Bailey-Lundberg

This study shows radiofrequency ablation reduces tumor growth and alters the tumor microenvironment in a mouse model of pancreatic cancer, suggesting potential for combination therapies.

bioRxiv · Jan 7, 2022 · PreprintCancer Biology